Genneve, a Seattle-based digital health company for women in midlife & menopause has raised $4M in seed funding led by BlueRun Ventures including participation from Maven Ventures and Startup Health. The latest round brings the startup’s total funding to date to $5.3 million, GeekWire first reports.
Telemedicine Clinic for Menopause
Every woman will experience menopause which lasts 4-10 years, costing her on average $20k through trial-and-error spending on prescriptions, doctor visits, treatments, devices and products. Founded in 2010 by former Microsoft executive Jill Angelo, Genneve is first-of-its-kind telemedicine clinic for menopause where women can book video appointments with practitioners specialized in menopause.
Available now in 23 states, each appointment costs $65 to speak with an MD and $45 to consult with a nurse practitioner that lasts 15 minutes. Insurance is not accepted at this time, but prescriptions covered by the patient’s insurance plan will qualify and will be taken care of by the chosen patient’s pharmacy.
In addition, Genneve curates’ products for hormone-driven relief symptoms (e.g. hot flashes, insomnia, anxiety, loss of libido); offers menopause tools including the OB/GYN-created Menopause Assessment and free access to physician-informed blogs, podcasts and videos on menopause symptoms and remedies. As a cloud-based health concierge and community, Genneve has a community network of women and practitioners dialoguing about their own menopause journeys.
The company plans to use the seed funding to grow the company’s user base and geographic footprint to all 50 states.
